| Pfizer AG - Prevenar 20, Injektionssuspension in einer Fertigspritze | | 69222 | | 01 | | Prevenar 20 | | Injektionssuspension in einer Fertigspritze | | J07AL02 | | Pneumococcus, Purified Polysaccharides Antigen Conjugated | | 26.03.2024 | | |
| | Composition | | polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 6B conjugata cum proteino corynebacteriae diphtheriae CRM 197 4.4 µg, polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 8 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 9V conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 10A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 11A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 12F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 15B conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 18C conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 19F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 22F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 23F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 33F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida 46.2 µg et proteinum corynebacteriae diphtheriae CRM 197 51 µg, adjuvans: aluminium 0.125 mg ut aluminii phosphas, acidum succinicum, natrii chloridum corresp. natrium 1.73 mg, polysorbatum 80, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, | | Packungsbestandteile | | Injektionssuspension in einer Fertigspritze | | | | | | | | Active Agent | Dose |
|---|
| Polysaccharida Streptococci Pneumoniae Typus 10a Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 11a Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 12f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 15b Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 18c Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 19a Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 19f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 22f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 23f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 33f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 6A Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 6B Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 4.4µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 7F Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | Polysaccharida Streptococci Pneumoniae Typus 9V Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml |
| | BAG: Active Agent |
|---|
| Vaccinum Pneumococcale Polysaccharidicum crm Conjugatum 20-Valens |
| | | | Inactive agents | Dose | additional_information |
|---|
| Succinic Acid | | | | Alumine | 0.125mg / 0.5ml | adjuvans | | Conjugata cum Proteino Corynebacteriae Diphtheriae crm 197 | 2.2µg / 0.5ml | | | Sodium Chloride | | | | Polysaccharida | 46.2µg / 0.5ml | | | Polysaccharida Streptococci Pneumoniae Typus | 14 | | | Polysorbatum 80 | | | | Proteinum Corynebacteriae Diphtheriae crm 197 | 51µg / 0.5ml | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 59.21 | 80.80 | B | SL | No | | 002 | 10 | 592.10 | 660.35 | B | SL | No |
|
|
